The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Escherichia Coli (E. Coli) Diagnostic Testing Market Research Report 2025
Synopsis
Escherichia coli (E. coli), is a bacterium which normally lives in the intestines of humans and animals.
The global Escherichia Coli (E. Coli) Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Escherichia Coli (E. Coli) Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Escherichia Coli (E. Coli) Diagnostic Testing.
Report Scope
The Escherichia Coli (E. Coli) Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Escherichia Coli (E. Coli) Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Escherichia Coli (E. Coli) Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Beckman Coulter
Wako
Becton
Dickinson and Company
Affymetrix
bioMérieux
Bio-Rad Laboratories
Thermo Fisher Scientific
Siemens
Hoffmann-La Roche
Cepheid
GenBio
Olympus
Novartis
Johnson & Johnson
Segment by Type
Monoclonal Antibodies
Molecular Diagnostics
Differential Light Scattering
Immunoassays
Flow Cytometry
Chromatography
Diagnostic Imaging
Segment by Application
Commercial or Private Labs
Hospitals
Public Health Labs
Academic Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Escherichia Coli (E. Coli) Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Escherichia coli (E. coli), is a bacterium which normally lives in the intestines of humans and animals.
The global Escherichia Coli (E. Coli) Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Escherichia Coli (E. Coli) Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Escherichia Coli (E. Coli) Diagnostic Testing.
Report Scope
The Escherichia Coli (E. Coli) Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Escherichia Coli (E. Coli) Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Escherichia Coli (E. Coli) Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Beckman Coulter
Wako
Becton
Dickinson and Company
Affymetrix
bioMérieux
Bio-Rad Laboratories
Thermo Fisher Scientific
Siemens
Hoffmann-La Roche
Cepheid
GenBio
Olympus
Novartis
Johnson & Johnson
Segment by Type
Monoclonal Antibodies
Molecular Diagnostics
Differential Light Scattering
Immunoassays
Flow Cytometry
Chromatography
Diagnostic Imaging
Segment by Application
Commercial or Private Labs
Hospitals
Public Health Labs
Academic Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Escherichia Coli (E. Coli) Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Molecular Diagnostics
1.2.4 Differential Light Scattering
1.2.5 Immunoassays
1.2.6 Flow Cytometry
1.2.7 Chromatography
1.2.8 Diagnostic Imaging
1.3 Market by Application
1.3.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial or Private Labs
1.3.3 Hospitals
1.3.4 Public Health Labs
1.3.5 Academic Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Perspective (2019-2030)
2.2 Escherichia Coli (E. Coli) Diagnostic Testing Growth Trends by Region
2.2.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Escherichia Coli (E. Coli) Diagnostic Testing Historic Market Size by Region (2019-2024)
2.2.3 Escherichia Coli (E. Coli) Diagnostic Testing Forecasted Market Size by Region (2025-2030)
2.3 Escherichia Coli (E. Coli) Diagnostic Testing Market Dynamics
2.3.1 Escherichia Coli (E. Coli) Diagnostic Testing Industry Trends
2.3.2 Escherichia Coli (E. Coli) Diagnostic Testing Market Drivers
2.3.3 Escherichia Coli (E. Coli) Diagnostic Testing Market Challenges
2.3.4 Escherichia Coli (E. Coli) Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Escherichia Coli (E. Coli) Diagnostic Testing Players by Revenue
3.1.1 Global Top Escherichia Coli (E. Coli) Diagnostic Testing Players by Revenue (2019-2024)
3.1.2 Global Escherichia Coli (E. Coli) Diagnostic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Escherichia Coli (E. Coli) Diagnostic Testing Revenue
3.4 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Concentration Ratio
3.4.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Escherichia Coli (E. Coli) Diagnostic Testing Revenue in 2023
3.5 Escherichia Coli (E. Coli) Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Escherichia Coli (E. Coli) Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Escherichia Coli (E. Coli) Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Escherichia Coli (E. Coli) Diagnostic Testing Breakdown Data by Type
4.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Historic Market Size by Type (2019-2024)
4.2 Global Escherichia Coli (E. Coli) Diagnostic Testing Forecasted Market Size by Type (2025-2030)
5 Escherichia Coli (E. Coli) Diagnostic Testing Breakdown Data by Application
5.1 Global Escherichia Coli (E. Coli) Diagnostic Testing Historic Market Size by Application (2019-2024)
5.2 Global Escherichia Coli (E. Coli) Diagnostic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Escherichia Coli (E. Coli) Diagnostic Testing Market Size (2019-2030)
6.2 North America Escherichia Coli (E. Coli) Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Escherichia Coli (E. Coli) Diagnostic Testing Market Size by Country (2019-2024)
6.4 North America Escherichia Coli (E. Coli) Diagnostic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Escherichia Coli (E. Coli) Diagnostic Testing Market Size (2019-2030)
7.2 Europe Escherichia Coli (E. Coli) Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Escherichia Coli (E. Coli) Diagnostic Testing Market Size by Country (2019-2024)
7.4 Europe Escherichia Coli (E. Coli) Diagnostic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Escherichia Coli (E. Coli) Diagnostic Testing Market Size (2019-2030)
8.2 Asia-Pacific Escherichia Coli (E. Coli) Diagnostic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Escherichia Coli (E. Coli) Diagnostic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Escherichia Coli (E. Coli) Diagnostic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Escherichia Coli (E. Coli) Diagnostic Testing Market Size (2019-2030)
9.2 Latin America Escherichia Coli (E. Coli) Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Escherichia Coli (E. Coli) Diagnostic Testing Market Size by Country (2019-2024)
9.4 Latin America Escherichia Coli (E. Coli) Diagnostic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Escherichia Coli (E. Coli) Diagnostic Testing Market Size (2019-2030)
10.2 Middle East & Africa Escherichia Coli (E. Coli) Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Escherichia Coli (E. Coli) Diagnostic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Escherichia Coli (E. Coli) Diagnostic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.1.4 Abbott Laboratories Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Detail
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.2.4 Beckman Coulter Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.2.5 Beckman Coulter Recent Development
11.3 Wako
11.3.1 Wako Company Detail
11.3.2 Wako Business Overview
11.3.3 Wako Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.3.4 Wako Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.3.5 Wako Recent Development
11.4 Becton
11.4.1 Becton Company Detail
11.4.2 Becton Business Overview
11.4.3 Becton Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.4.4 Becton Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.4.5 Becton Recent Development
11.5 Dickinson and Company
11.5.1 Dickinson and Company Company Detail
11.5.2 Dickinson and Company Business Overview
11.5.3 Dickinson and Company Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.5.4 Dickinson and Company Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.5.5 Dickinson and Company Recent Development
11.6 Affymetrix
11.6.1 Affymetrix Company Detail
11.6.2 Affymetrix Business Overview
11.6.3 Affymetrix Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.6.4 Affymetrix Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.6.5 Affymetrix Recent Development
11.7 bioMérieux
11.7.1 bioMérieux Company Detail
11.7.2 bioMérieux Business Overview
11.7.3 bioMérieux Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.7.4 bioMérieux Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.7.5 bioMérieux Recent Development
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Detail
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.8.4 Bio-Rad Laboratories Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.8.5 Bio-Rad Laboratories Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Detail
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.9.4 Thermo Fisher Scientific Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Siemens
11.10.1 Siemens Company Detail
11.10.2 Siemens Business Overview
11.10.3 Siemens Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.10.4 Siemens Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.10.5 Siemens Recent Development
11.11 Hoffmann-La Roche
11.11.1 Hoffmann-La Roche Company Detail
11.11.2 Hoffmann-La Roche Business Overview
11.11.3 Hoffmann-La Roche Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.11.4 Hoffmann-La Roche Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.11.5 Hoffmann-La Roche Recent Development
11.12 Cepheid
11.12.1 Cepheid Company Detail
11.12.2 Cepheid Business Overview
11.12.3 Cepheid Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.12.4 Cepheid Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.12.5 Cepheid Recent Development
11.13 GenBio
11.13.1 GenBio Company Detail
11.13.2 GenBio Business Overview
11.13.3 GenBio Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.13.4 GenBio Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.13.5 GenBio Recent Development
11.14 Olympus
11.14.1 Olympus Company Detail
11.14.2 Olympus Business Overview
11.14.3 Olympus Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.14.4 Olympus Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.14.5 Olympus Recent Development
11.15 Novartis
11.15.1 Novartis Company Detail
11.15.2 Novartis Business Overview
11.15.3 Novartis Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.15.4 Novartis Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.15.5 Novartis Recent Development
11.16 Johnson & Johnson
11.16.1 Johnson & Johnson Company Detail
11.16.2 Johnson & Johnson Business Overview
11.16.3 Johnson & Johnson Escherichia Coli (E. Coli) Diagnostic Testing Introduction
11.16.4 Johnson & Johnson Revenue in Escherichia Coli (E. Coli) Diagnostic Testing Business (2019-2024)
11.16.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
